Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 5.85815830 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.85815830 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.36040324 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.25082324 |
5 | L-phenylalanine catabolic process (GO:0006559) | 5.23859183 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.23859183 |
7 | L-phenylalanine metabolic process (GO:0006558) | 4.92007070 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.92007070 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.68795242 |
10 | protein carboxylation (GO:0018214) | 4.68044070 |
11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68044070 |
12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.67897626 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.67291842 |
14 | response to interleukin-15 (GO:0070672) | 4.61476096 |
15 | complement activation, alternative pathway (GO:0006957) | 4.60364694 |
16 | aromatic amino acid family catabolic process (GO:0009074) | 4.60287047 |
17 | cysteine metabolic process (GO:0006534) | 4.53554903 |
18 | sulfur amino acid catabolic process (GO:0000098) | 4.51775863 |
19 | urea cycle (GO:0000050) | 4.45804322 |
20 | urea metabolic process (GO:0019627) | 4.45804322 |
21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.44448566 |
22 | COPI coating of Golgi vesicle (GO:0048205) | 4.43683403 |
23 | Golgi transport vesicle coating (GO:0048200) | 4.43683403 |
24 | negative T cell selection (GO:0043383) | 4.42937769 |
25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.36116139 |
26 | negative thymic T cell selection (GO:0045060) | 4.35937737 |
27 | cellular response to interleukin-15 (GO:0071350) | 4.29409874 |
28 | tolerance induction (GO:0002507) | 4.26676951 |
29 | regulation of protein activation cascade (GO:2000257) | 4.25646891 |
30 | kynurenine metabolic process (GO:0070189) | 4.17739510 |
31 | regulation of cholesterol homeostasis (GO:2000188) | 4.16966613 |
32 | tryptophan catabolic process (GO:0006569) | 4.15406630 |
33 | indole-containing compound catabolic process (GO:0042436) | 4.15406630 |
34 | indolalkylamine catabolic process (GO:0046218) | 4.15406630 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 4.13980661 |
36 | tryptophan metabolic process (GO:0006568) | 4.09594526 |
37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.08961616 |
38 | T cell migration (GO:0072678) | 4.05426297 |
39 | regulation of complement activation (GO:0030449) | 4.05097851 |
40 | high-density lipoprotein particle remodeling (GO:0034375) | 4.04132540 |
41 | nitrogen cycle metabolic process (GO:0071941) | 3.99770480 |
42 | bile acid biosynthetic process (GO:0006699) | 3.97441224 |
43 | negative regulation of fibrinolysis (GO:0051918) | 3.97346310 |
44 | leukocyte aggregation (GO:0070486) | 3.94662383 |
45 | homocysteine metabolic process (GO:0050667) | 3.81990755 |
46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.75846114 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71428541 |
48 | reverse cholesterol transport (GO:0043691) | 3.70938754 |
49 | regulation of fibrinolysis (GO:0051917) | 3.69629998 |
50 | COPII vesicle coating (GO:0048208) | 3.67892903 |
51 | bile acid metabolic process (GO:0008206) | 3.66528023 |
52 | dendritic cell chemotaxis (GO:0002407) | 3.61841385 |
53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.61824226 |
54 | intestinal cholesterol absorption (GO:0030299) | 3.61316252 |
55 | bile acid and bile salt transport (GO:0015721) | 3.60708243 |
56 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.60367334 |
57 | cellular extravasation (GO:0045123) | 3.59596063 |
58 | response to muramyl dipeptide (GO:0032495) | 3.56773437 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.54649714 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.54649714 |
61 | modulation by symbiont of host immune response (GO:0052553) | 3.54649714 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 3.54649714 |
63 | modulation by symbiont of host defense response (GO:0052031) | 3.54649714 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.54649714 |
65 | valine metabolic process (GO:0006573) | 3.52995051 |
66 | positive thymic T cell selection (GO:0045059) | 3.51251596 |
67 | plasma lipoprotein particle assembly (GO:0034377) | 3.50369276 |
68 | positive T cell selection (GO:0043368) | 3.48714483 |
69 | serine family amino acid catabolic process (GO:0009071) | 3.48571616 |
70 | glyoxylate metabolic process (GO:0046487) | 3.46678012 |
71 | phospholipid homeostasis (GO:0055091) | 3.46644816 |
72 | acylglycerol homeostasis (GO:0055090) | 3.46357471 |
73 | triglyceride homeostasis (GO:0070328) | 3.46357471 |
74 | phospholipid efflux (GO:0033700) | 3.44444116 |
75 | T cell selection (GO:0045058) | 3.44141171 |
76 | thymic T cell selection (GO:0045061) | 3.43707398 |
77 | lysine metabolic process (GO:0006553) | 3.41488820 |
78 | lysine catabolic process (GO:0006554) | 3.41488820 |
79 | macroautophagy (GO:0016236) | 3.39899165 |
80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.38844646 |
81 | protein-lipid complex remodeling (GO:0034368) | 3.38844646 |
82 | macromolecular complex remodeling (GO:0034367) | 3.38844646 |
83 | neutrophil activation involved in immune response (GO:0002283) | 3.37240503 |
84 | dendritic cell migration (GO:0036336) | 3.37147275 |
85 | negative regulation of interleukin-12 production (GO:0032695) | 3.36033302 |
86 | detection of other organism (GO:0098543) | 3.35728077 |
87 | negative regulation of cholesterol transport (GO:0032375) | 3.34232828 |
88 | negative regulation of sterol transport (GO:0032372) | 3.34232828 |
89 | protein-lipid complex assembly (GO:0065005) | 3.33781944 |
90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.33774570 |
91 | neutrophil activation (GO:0042119) | 3.31873858 |
92 | aromatic amino acid family metabolic process (GO:0009072) | 3.31113670 |
93 | cellular modified amino acid catabolic process (GO:0042219) | 3.29429710 |
94 | regulation of triglyceride catabolic process (GO:0010896) | 3.28430625 |
95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27840563 |
96 | tyrosine metabolic process (GO:0006570) | 3.27773677 |
97 | activated T cell proliferation (GO:0050798) | 3.25731265 |
98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24309266 |
99 | cholesterol efflux (GO:0033344) | 3.22496388 |
100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22459603 |
101 | plasma lipoprotein particle clearance (GO:0034381) | 3.21919004 |
102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.21200807 |
103 | detection of bacterium (GO:0016045) | 3.19912389 |
104 | macrophage activation involved in immune response (GO:0002281) | 3.19864045 |
105 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17137796 |
106 | positive regulation of granulocyte differentiation (GO:0030854) | 3.16471171 |
107 | detection of molecule of bacterial origin (GO:0032490) | 3.15827761 |
108 | complement activation, classical pathway (GO:0006958) | 3.15561027 |
109 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.13069581 |
110 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12307584 |
111 | amino-acid betaine metabolic process (GO:0006577) | 3.11017032 |
112 | indolalkylamine metabolic process (GO:0006586) | 3.10808565 |
113 | coenzyme catabolic process (GO:0009109) | 3.10176717 |
114 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08190034 |
115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08190034 |
116 | complement activation (GO:0006956) | 3.07680602 |
117 | response to type I interferon (GO:0034340) | 3.07393014 |
118 | type I interferon signaling pathway (GO:0060337) | 3.06008565 |
119 | cellular response to type I interferon (GO:0071357) | 3.06008565 |
120 | regulation of T cell tolerance induction (GO:0002664) | 3.05745933 |
121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05697807 |
122 | T-helper cell differentiation (GO:0042093) | 3.05514728 |
123 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.05514728 |
124 | plasma lipoprotein particle organization (GO:0071827) | 3.05319586 |
125 | detection of external biotic stimulus (GO:0098581) | 3.05230906 |
126 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04887210 |
127 | granulocyte activation (GO:0036230) | 3.04233716 |
128 | acute-phase response (GO:0006953) | 3.03605103 |
129 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.02441458 |
130 | neutrophil mediated immunity (GO:0002446) | 3.01864893 |
131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.01138130 |
132 | fibrinolysis (GO:0042730) | 2.99424415 |
133 | response to peptidoglycan (GO:0032494) | 2.99149320 |
134 | alpha-amino acid catabolic process (GO:1901606) | 2.99070130 |
135 | B cell receptor signaling pathway (GO:0050853) | 2.98909825 |
136 | germinal center formation (GO:0002467) | 2.98770700 |
137 | protein-lipid complex subunit organization (GO:0071825) | 2.98594664 |
138 | regulation of B cell differentiation (GO:0045577) | 2.98298918 |
139 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.97974269 |
140 | * positive regulation of nuclease activity (GO:0032075) | 2.97603763 |
141 | 4-hydroxyproline metabolic process (GO:0019471) | 2.97589182 |
142 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.95116951 |
143 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.95116951 |
144 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.93703417 |
145 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92360620 |
146 | ethanol oxidation (GO:0006069) | 2.92196081 |
147 | protein activation cascade (GO:0072376) | 2.91651032 |
148 | interferon-gamma production (GO:0032609) | 2.91190758 |
149 | interferon-gamma secretion (GO:0072643) | 2.90842101 |
150 | benzene-containing compound metabolic process (GO:0042537) | 2.89375524 |
151 | one-carbon metabolic process (GO:0006730) | 2.89342899 |
152 | lipoprotein metabolic process (GO:0042157) | 2.88213211 |
153 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87636311 |
154 | regulation of tolerance induction (GO:0002643) | 2.84781879 |
155 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.84760318 |
156 | 2-oxoglutarate metabolic process (GO:0006103) | 2.84674357 |
157 | intestinal absorption (GO:0050892) | 2.83675939 |
158 | cytolysis (GO:0019835) | 2.83444807 |
159 | glutamate metabolic process (GO:0006536) | 2.83244216 |
160 | negative regulation of lipase activity (GO:0060192) | 2.82846404 |
161 | positive regulation of tolerance induction (GO:0002645) | 2.82728142 |
162 | mannose metabolic process (GO:0006013) | 2.81718366 |
163 | cellular amino acid catabolic process (GO:0009063) | 2.80680408 |
164 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79831967 |
165 | sterol homeostasis (GO:0055092) | 2.79812996 |
166 | cholesterol homeostasis (GO:0042632) | 2.79773077 |
167 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 2.78626622 |
168 | leukocyte degranulation (GO:0043299) | 2.77587827 |
169 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77485487 |
170 | drug transmembrane transport (GO:0006855) | 2.77437615 |
171 | imidazole-containing compound metabolic process (GO:0052803) | 2.77289791 |
172 | glycine metabolic process (GO:0006544) | 2.76965739 |
173 | myeloid cell activation involved in immune response (GO:0002275) | 2.76719068 |
174 | hormone catabolic process (GO:0042447) | 2.75683758 |
175 | positive regulation of interleukin-2 production (GO:0032743) | 2.75436017 |
176 | negative regulation of lipid transport (GO:0032369) | 2.75318666 |
177 | regulation of necroptotic process (GO:0060544) | 2.73345782 |
178 | negative regulation of innate immune response (GO:0045824) | 2.72090059 |
179 | mast cell activation (GO:0045576) | 2.71723421 |
180 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.71292564 |
181 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.69924230 |
182 | detection of biotic stimulus (GO:0009595) | 2.68778162 |
183 | positive regulation of B cell differentiation (GO:0045579) | 2.68615072 |
184 | regulation of cell killing (GO:0031341) | 2.68274896 |
185 | regulation of T cell mediated immunity (GO:0002709) | 2.66371090 |
186 | hepatocyte apoptotic process (GO:0097284) | 2.66336283 |
187 | T cell differentiation involved in immune response (GO:0002292) | 2.66201434 |
188 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.66201434 |
189 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.66201434 |
190 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65236639 |
191 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.64671720 |
192 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64319063 |
193 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63688367 |
194 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.63621683 |
195 | lymphocyte migration (GO:0072676) | 2.62815159 |
196 | cellular response to ethanol (GO:0071361) | 2.62153946 |
197 | B cell homeostasis (GO:0001782) | 2.62042362 |
198 | T cell receptor signaling pathway (GO:0050852) | 2.60047802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.60303927 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.75898480 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.43725713 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.09498701 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.83313284 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.01574731 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.45931894 |
8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.36631076 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.22924289 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.16976555 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.01350947 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.87480371 |
13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.63432006 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.51629873 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48764891 |
16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.45429936 |
17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.25308177 |
18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.21576851 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16431807 |
20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16236749 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.13150939 |
22 | SPI1_23127762_ChIP-Seq_K562_Human | 1.97291995 |
23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96740932 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.95923480 |
25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84491138 |
26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79703736 |
27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76952018 |
28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75936797 |
29 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74859816 |
30 | GATA3_26560356_Chip-Seq_TH2_Human | 1.74417604 |
31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74004399 |
32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.72343293 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71835395 |
34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67333326 |
35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.66804126 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66644395 |
37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64601279 |
38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61925450 |
39 | MAF_26560356_Chip-Seq_TH2_Human | 1.61301485 |
40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55476928 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52836819 |
42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50321127 |
43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50123318 |
44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45985044 |
45 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44533829 |
46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43686896 |
47 | MYC_22102868_ChIP-Seq_BL_Human | 1.42864569 |
48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41374328 |
49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40844535 |
50 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.38667301 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36993504 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36253659 |
53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35556925 |
54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.35449446 |
55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31889736 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29268578 |
57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28439265 |
58 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27794815 |
59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27212542 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25960638 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25636719 |
62 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23742022 |
63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23237720 |
64 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21666145 |
65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19670670 |
66 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19304815 |
67 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17061868 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15633266 |
69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14681534 |
70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14375184 |
71 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14270387 |
72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13907998 |
73 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12536458 |
74 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12291022 |
75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11862474 |
76 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11749426 |
77 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09997820 |
78 | MYB_26560356_Chip-Seq_TH1_Human | 1.09562588 |
79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08846131 |
80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08772749 |
81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07995341 |
82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06992339 |
83 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06314135 |
84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05917598 |
85 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05168784 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04403293 |
87 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04265070 |
88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03235756 |
89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02930015 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02740965 |
91 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00834068 |
92 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00586153 |
93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00094384 |
94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99641654 |
95 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99605837 |
96 | MYB_26560356_Chip-Seq_TH2_Human | 0.98868234 |
97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98411244 |
98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95782964 |
99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94907233 |
100 | MAF_26560356_Chip-Seq_TH1_Human | 0.94524053 |
101 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94089122 |
102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94084089 |
103 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93728335 |
104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93155807 |
105 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93094047 |
106 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92075179 |
107 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.90842031 |
108 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90066842 |
109 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90064440 |
110 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89522880 |
111 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89098722 |
112 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89059174 |
113 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87910678 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87439373 |
115 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86619475 |
116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85415862 |
117 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85364150 |
118 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85132412 |
119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84304497 |
120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84013870 |
121 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83725029 |
122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83630094 |
123 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.82715735 |
124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82474197 |
125 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82041779 |
126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.80965772 |
127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.80212415 |
128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80078463 |
129 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.79978980 |
130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79195466 |
131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79008934 |
132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79008934 |
133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78945090 |
134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78669669 |
135 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.78030657 |
136 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77821684 |
137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76974198 |
138 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.75047461 |
139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72313527 |
140 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72146231 |
141 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.71708727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.75384879 |
2 | MP0005360_urolithiasis | 4.97923991 |
3 | MP0005365_abnormal_bile_salt | 4.90245797 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.26606374 |
5 | MP0003252_abnormal_bile_duct | 3.56645247 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.42788935 |
7 | MP0005671_abnormal_response_to | 3.41457434 |
8 | MP0003763_abnormal_thymus_physiology | 3.32791467 |
9 | MP0005000_abnormal_immune_tolerance | 2.93499056 |
10 | MP0009840_abnormal_foam_cell | 2.81358755 |
11 | MP0010329_abnormal_lipoprotein_level | 2.70358846 |
12 | MP0002723_abnormal_immune_serum | 2.65368531 |
13 | MP0009785_altered_susceptibility_to | 2.65201722 |
14 | MP0002452_abnormal_antigen_presenting | 2.51621389 |
15 | MP0002420_abnormal_adaptive_immunity | 2.47620305 |
16 | MP0001819_abnormal_immune_cell | 2.45742558 |
17 | MP0001666_abnormal_nutrient_absorption | 2.44565188 |
18 | MP0003300_gastrointestinal_ulcer | 2.42480384 |
19 | MP0003195_calcinosis | 2.41749515 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.36941225 |
21 | MP0005083_abnormal_biliary_tract | 2.32554884 |
22 | MP0002877_abnormal_melanocyte_morpholog | 2.19709195 |
23 | MP0002405_respiratory_system_inflammati | 2.12613754 |
24 | MP0000609_abnormal_liver_physiology | 2.08985253 |
25 | MP0006082_CNS_inflammation | 2.06127466 |
26 | MP0003806_abnormal_nucleotide_metabolis | 2.03997036 |
27 | MP0003868_abnormal_feces_composition | 2.03029364 |
28 | MP0009333_abnormal_splenocyte_physiolog | 2.01391147 |
29 | * MP0002398_abnormal_bone_marrow | 1.95642605 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.92582936 |
31 | * MP0000716_abnormal_immune_system | 1.90985606 |
32 | MP0002138_abnormal_hepatobiliary_system | 1.88717178 |
33 | MP0003705_abnormal_hypodermis_morpholog | 1.84966405 |
34 | MP0002009_preneoplasia | 1.72980425 |
35 | MP0005220_abnormal_exocrine_pancreas | 1.68470807 |
36 | MP0000689_abnormal_spleen_morphology | 1.67693682 |
37 | MP0002722_abnormal_immune_system | 1.66613487 |
38 | MP0002118_abnormal_lipid_homeostasis | 1.65280987 |
39 | MP0005058_abnormal_lysosome_morphology | 1.65156394 |
40 | MP0005332_abnormal_amino_acid | 1.64372724 |
41 | MP0000703_abnormal_thymus_morphology | 1.64140031 |
42 | MP0004381_abnormal_hair_follicle | 1.62689737 |
43 | MP0003866_abnormal_defecation | 1.55736801 |
44 | MP0005319_abnormal_enzyme/_coenzyme | 1.52772070 |
45 | MP0003828_pulmonary_edema | 1.52319696 |
46 | * MP0002429_abnormal_blood_cell | 1.48484631 |
47 | MP0009643_abnormal_urine_homeostasis | 1.42894976 |
48 | MP0002998_abnormal_bone_remodeling | 1.42354901 |
49 | MP0010234_abnormal_vibrissa_follicle | 1.42352617 |
50 | MP0002933_joint_inflammation | 1.38415261 |
51 | MP0001851_eye_inflammation | 1.37936877 |
52 | MP0002693_abnormal_pancreas_physiology | 1.36410474 |
53 | MP0004019_abnormal_vitamin_homeostasis | 1.36287889 |
54 | MP0001944_abnormal_pancreas_morphology | 1.35880746 |
55 | MP0002928_abnormal_bile_duct | 1.29115897 |
56 | MP0002396_abnormal_hematopoietic_system | 1.22763533 |
57 | MP0002909_abnormal_adrenal_gland | 1.21743615 |
58 | MP0003656_abnormal_erythrocyte_physiolo | 1.21379333 |
59 | MP0004883_abnormal_blood_vessel | 1.21048690 |
60 | MP0005075_abnormal_melanosome_morpholog | 1.18680441 |
61 | * MP0000598_abnormal_liver_morphology | 1.18625533 |
62 | MP0000858_altered_metastatic_potential | 1.17626861 |
63 | MP0003436_decreased_susceptibility_to | 1.17418976 |
64 | MP0005464_abnormal_platelet_physiology | 1.15667603 |
65 | * MP0004264_abnormal_extraembryonic_tissu | 1.15018655 |
66 | MP0005408_hypopigmentation | 1.14751953 |
67 | MP0002166_altered_tumor_susceptibility | 1.14476326 |
68 | MP0005164_abnormal_response_to | 1.14208267 |
69 | MP0004947_skin_inflammation | 1.13894976 |
70 | MP0008004_abnormal_stomach_pH | 1.12708707 |
71 | MP0005451_abnormal_body_composition | 1.11929886 |
72 | * MP0002078_abnormal_glucose_homeostasis | 1.11729073 |
73 | MP0003183_abnormal_peptide_metabolism | 1.08141256 |
74 | MP0003303_peritoneal_inflammation | 1.07585396 |
75 | MP0008469_abnormal_protein_level | 1.05687215 |
76 | MP0010368_abnormal_lymphatic_system | 1.05029379 |
77 | MP0005076_abnormal_cell_differentiation | 1.01770432 |
78 | MP0001765_abnormal_ion_homeostasis | 1.00363145 |
79 | MP0009763_increased_sensitivity_to | 0.99699620 |
80 | MP0005636_abnormal_mineral_homeostasis | 0.98802809 |
81 | MP0003172_abnormal_lysosome_physiology | 0.98760222 |
82 | MP0008961_abnormal_basal_metabolism | 0.97692185 |
83 | MP0001853_heart_inflammation | 0.97144237 |
84 | MP0005647_abnormal_sex_gland | 0.94679269 |
85 | MP0009278_abnormal_bone_marrow | 0.94079230 |
86 | MP0000569_abnormal_digit_pigmentation | 0.93344454 |
87 | MP0003724_increased_susceptibility_to | 0.93050696 |
88 | MP0003566_abnormal_cell_adhesion | 0.93008258 |
89 | MP0009764_decreased_sensitivity_to | 0.92756810 |
90 | MP0001764_abnormal_homeostasis | 0.92383066 |
91 | MP0001756_abnormal_urination | 0.91531286 |
92 | MP0001845_abnormal_inflammatory_respons | 0.90516171 |
93 | MP0001881_abnormal_mammary_gland | 0.90107382 |
94 | MP0000685_abnormal_immune_system | 0.89336935 |
95 | MP0003690_abnormal_glial_cell | 0.88435518 |
96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88210777 |
97 | MP0008260_abnormal_autophagy | 0.86458949 |
98 | MP0009642_abnormal_blood_homeostasis | 0.86308116 |
99 | MP0000249_abnormal_blood_vessel | 0.86075501 |
100 | MP0005310_abnormal_salivary_gland | 0.84884687 |
101 | MP0010155_abnormal_intestine_physiology | 0.84870779 |
102 | MP0010352_gastrointestinal_tract_polyps | 0.83733121 |
103 | MP0005166_decreased_susceptibility_to | 0.83477861 |
104 | MP0000604_amyloidosis | 0.82902184 |
105 | MP0004510_myositis | 0.82523541 |
106 | MP0002254_reproductive_system_inflammat | 0.82222790 |
107 | MP0002132_abnormal_respiratory_system | 0.81666692 |
108 | MP0003448_altered_tumor_morphology | 0.81300512 |
109 | MP0001873_stomach_inflammation | 0.79608666 |
110 | MP0005334_abnormal_fat_pad | 0.79562658 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.79043631 |
112 | MP0002419_abnormal_innate_immunity | 0.78965019 |
113 | MP0004808_abnormal_hematopoietic_stem | 0.78456225 |
114 | MP0005397_hematopoietic_system_phenotyp | 0.76679500 |
115 | MP0001545_abnormal_hematopoietic_system | 0.76679500 |
116 | MP0005390_skeleton_phenotype | 0.75937047 |
117 | MP0005387_immune_system_phenotype | 0.75793030 |
118 | MP0001790_abnormal_immune_system | 0.75793030 |
119 | MP0000639_abnormal_adrenal_gland | 0.75047910 |
120 | MP0002277_abnormal_respiratory_mucosa | 0.73505555 |
121 | MP0001533_abnormal_skeleton_physiology | 0.73304421 |
122 | MP0005670_abnormal_white_adipose | 0.73090892 |
123 | MP0002136_abnormal_kidney_physiology | 0.72809378 |
124 | MP0000371_diluted_coat_color | 0.72752202 |
125 | MP0003075_altered_response_to | 0.71773183 |
126 | MP0009780_abnormal_chondrocyte_physiolo | 0.70828468 |
127 | MP0005395_other_phenotype | 0.70267833 |
128 | MP0000015_abnormal_ear_pigmentation | 0.69175811 |
129 | MP0009765_abnormal_xenobiotic_induced | 0.68350655 |
130 | MP0006054_spinal_hemorrhage | 0.68289547 |
131 | MP0005023_abnormal_wound_healing | 0.68013341 |
132 | MP0003795_abnormal_bone_structure | 0.67971144 |
133 | MP0005167_abnormal_blood-brain_barrier | 0.67248239 |
134 | MP0002060_abnormal_skin_morphology | 0.67217592 |
135 | MP0002168_other_aberrant_phenotype | 0.66150559 |
136 | MP0003045_fibrosis | 0.65298330 |
137 | MP0003453_abnormal_keratinocyte_physiol | 0.64135321 |
138 | MP0000465_gastrointestinal_hemorrhage | 0.63878678 |
139 | MP0002006_tumorigenesis | 0.63638847 |
140 | MP0003953_abnormal_hormone_level | 0.63094311 |
141 | MP0001663_abnormal_digestive_system | 0.61005247 |
142 | MP0001800_abnormal_humoral_immune | 0.60850522 |
143 | MP0001835_abnormal_antigen_presentation | 0.60790297 |
144 | MP0004130_abnormal_muscle_cell | 0.60437892 |
145 | MP0003186_abnormal_redox_activity | 0.59972861 |
146 | MP0001501_abnormal_sleep_pattern | 0.59419718 |
147 | MP0005025_abnormal_response_to | 0.59223258 |
148 | MP0010307_abnormal_tumor_latency | 0.58912842 |
149 | MP0005174_abnormal_tail_pigmentation | 0.58906500 |
150 | MP0003699_abnormal_female_reproductive | 0.58849367 |
151 | MP0001915_intracranial_hemorrhage | 0.58165027 |
152 | MP0009672_abnormal_birth_weight | 0.57778367 |
153 | MP0004782_abnormal_surfactant_physiolog | 0.57239324 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.90195707 |
2 | Eczematoid dermatitis (HP:0000976) | 5.57421528 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.47201669 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.98783477 |
5 | Myositis (HP:0100614) | 4.93000239 |
6 | Stomatitis (HP:0010280) | 4.79472646 |
7 | T lymphocytopenia (HP:0005403) | 4.79468363 |
8 | Optic neuritis (HP:0100653) | 4.79443106 |
9 | Retrobulbar optic neuritis (HP:0100654) | 4.79443106 |
10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.75464055 |
11 | Orchitis (HP:0100796) | 4.73587949 |
12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.65647376 |
13 | Abnormality of T cell number (HP:0011839) | 4.60282456 |
14 | Complement deficiency (HP:0004431) | 4.47130011 |
15 | Prolonged partial thromboplastin time (HP:0003645) | 4.45456773 |
16 | Xanthomatosis (HP:0000991) | 4.36967144 |
17 | Abnormality of the intrinsic pathway (HP:0010989) | 4.33249919 |
18 | Recurrent bacterial skin infections (HP:0005406) | 4.18491923 |
19 | Hypoglycemic coma (HP:0001325) | 4.16265044 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.10660069 |
21 | Recurrent abscess formation (HP:0002722) | 4.03749717 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.02814625 |
23 | Recurrent fungal infections (HP:0002841) | 3.89090122 |
24 | Abnormality of T cells (HP:0002843) | 3.79645907 |
25 | Abnormality of macrophages (HP:0004311) | 3.78884793 |
26 | Joint hemorrhage (HP:0005261) | 3.74660962 |
27 | Pustule (HP:0200039) | 3.74229920 |
28 | Hypobetalipoproteinemia (HP:0003563) | 3.60535105 |
29 | Hypoglycemic seizures (HP:0002173) | 3.55262894 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.49953884 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47374267 |
32 | Pulmonary infiltrates (HP:0002113) | 3.46641191 |
33 | Keratoconjunctivitis sicca (HP:0001097) | 3.46152559 |
34 | Vasculitis (HP:0002633) | 3.44848920 |
35 | Ketosis (HP:0001946) | 3.42146647 |
36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.34194541 |
37 | Fat malabsorption (HP:0002630) | 3.33597049 |
38 | Abnormality of complement system (HP:0005339) | 3.31777024 |
39 | Recurrent viral infections (HP:0004429) | 3.31350543 |
40 | Hyperlipoproteinemia (HP:0010980) | 3.30959345 |
41 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30352714 |
42 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30352714 |
43 | Keratoconjunctivitis (HP:0001096) | 3.26232550 |
44 | Myocardial infarction (HP:0001658) | 3.24450563 |
45 | Encephalitis (HP:0002383) | 3.24117016 |
46 | Hyperglycemia (HP:0003074) | 3.23560079 |
47 | Meningitis (HP:0001287) | 3.21885653 |
48 | Abnormality of T cell physiology (HP:0011840) | 3.20512171 |
49 | Increased IgE level (HP:0003212) | 3.18619243 |
50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.17077912 |
51 | IgG deficiency (HP:0004315) | 3.15552054 |
52 | Spontaneous hematomas (HP:0007420) | 3.14119324 |
53 | Recurrent skin infections (HP:0001581) | 3.13630768 |
54 | Epidermoid cyst (HP:0200040) | 3.06994701 |
55 | Ketoacidosis (HP:0001993) | 3.04627392 |
56 | Leukocytosis (HP:0001974) | 3.02757604 |
57 | Autoimmune hemolytic anemia (HP:0001890) | 2.95800799 |
58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95430883 |
59 | Hypolipoproteinemia (HP:0010981) | 2.95293524 |
60 | Panhypogammaglobulinemia (HP:0003139) | 2.93213840 |
61 | Abnormality of eosinophils (HP:0001879) | 2.92475587 |
62 | Hypoalphalipoproteinemia (HP:0003233) | 2.85612483 |
63 | Prolonged bleeding time (HP:0003010) | 2.84324999 |
64 | Inflammation of the large intestine (HP:0002037) | 2.81558147 |
65 | Granulocytopenia (HP:0001913) | 2.80428318 |
66 | Hemoptysis (HP:0002105) | 2.80405757 |
67 | Autoimmune thrombocytopenia (HP:0001973) | 2.80057213 |
68 | Mucopolysacchariduria (HP:0008155) | 2.76760716 |
69 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76760716 |
70 | Eosinophilia (HP:0001880) | 2.76356637 |
71 | Recurrent bronchitis (HP:0002837) | 2.73756545 |
72 | Menorrhagia (HP:0000132) | 2.73330520 |
73 | Joint swelling (HP:0001386) | 2.69986577 |
74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.69881931 |
75 | Late onset (HP:0003584) | 2.69688249 |
76 | Increased IgM level (HP:0003496) | 2.69265630 |
77 | Severe combined immunodeficiency (HP:0004430) | 2.66558066 |
78 | Gingivitis (HP:0000230) | 2.65852888 |
79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65755638 |
80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65755638 |
81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65755638 |
82 | Gastrointestinal inflammation (HP:0004386) | 2.64468607 |
83 | Hyperammonemia (HP:0001987) | 2.61965111 |
84 | Gingival bleeding (HP:0000225) | 2.60376299 |
85 | Gangrene (HP:0100758) | 2.58841410 |
86 | Colitis (HP:0002583) | 2.58653660 |
87 | Symptomatic seizures (HP:0011145) | 2.58566025 |
88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57710503 |
89 | Systemic lupus erythematosus (HP:0002725) | 2.57173218 |
90 | Hypercholesterolemia (HP:0003124) | 2.57160497 |
91 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.56776049 |
92 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.56776049 |
93 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.53309336 |
94 | Skin nodule (HP:0200036) | 2.52278765 |
95 | Abnormality of purine metabolism (HP:0004352) | 2.51160773 |
96 | Chest pain (HP:0100749) | 2.50303483 |
97 | Obstructive lung disease (HP:0006536) | 2.48467335 |
98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48467335 |
99 | Hematochezia (HP:0002573) | 2.43112095 |
100 | Urticaria (HP:0001025) | 2.41721480 |
101 | Hyperglycinemia (HP:0002154) | 2.40817773 |
102 | Hepatocellular carcinoma (HP:0001402) | 2.39630603 |
103 | Anorexia (HP:0002039) | 2.39551053 |
104 | Esophageal varix (HP:0002040) | 2.38829851 |
105 | Chronic diarrhea (HP:0002028) | 2.35601169 |
106 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35477515 |
107 | Hyperbilirubinemia (HP:0002904) | 2.34970309 |
108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.34722351 |
109 | Dysostosis multiplex (HP:0000943) | 2.33678873 |
110 | Pancreatitis (HP:0001733) | 2.30704607 |
111 | Steatorrhea (HP:0002570) | 2.28429024 |
112 | Abnormality of methionine metabolism (HP:0010901) | 2.27023736 |
113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25849104 |
114 | Stomach cancer (HP:0012126) | 2.25333681 |
115 | IgM deficiency (HP:0002850) | 2.25224671 |
116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25166116 |
117 | Hyperglycinuria (HP:0003108) | 2.25119780 |
118 | Lymphopenia (HP:0001888) | 2.24384732 |
119 | Glomerulonephritis (HP:0000099) | 2.22088140 |
120 | Mitral stenosis (HP:0001718) | 2.18831345 |
121 | Vacuolated lymphocytes (HP:0001922) | 2.18351675 |
122 | Episodic fever (HP:0001954) | 2.17604485 |
123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.16629920 |
124 | Acanthocytosis (HP:0001927) | 2.16259548 |
125 | Hypergammaglobulinemia (HP:0010702) | 2.15855174 |
126 | Verrucae (HP:0200043) | 2.15527741 |
127 | Papilloma (HP:0012740) | 2.15527741 |
128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.13483478 |
129 | Hypochromic anemia (HP:0001931) | 2.13342251 |
130 | Thrombophlebitis (HP:0004418) | 2.13269223 |
131 | Agammaglobulinemia (HP:0004432) | 2.12489788 |
132 | Abnormality of the pleura (HP:0002103) | 2.10880547 |
133 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09935284 |
134 | Abnormality of glycine metabolism (HP:0010895) | 2.09935284 |
135 | Papilledema (HP:0001085) | 2.08364608 |
136 | Insulin resistance (HP:0000855) | 2.07650794 |
137 | Combined immunodeficiency (HP:0005387) | 2.06094847 |
138 | Keratitis (HP:0000491) | 2.05200685 |
139 | Abnormality of the fingertips (HP:0001211) | 2.04417178 |
140 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04110998 |
141 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.02342085 |
142 | Glomerulopathy (HP:0100820) | 2.02048792 |
143 | Hypochromic microcytic anemia (HP:0004840) | 2.00804620 |
144 | Increased cerebral lipofuscin (HP:0011813) | 2.00549640 |
145 | Gastrointestinal stroma tumor (HP:0100723) | 1.99209227 |
146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98942961 |
147 | Aneurysm (HP:0002617) | 1.98491273 |
148 | Arterial thrombosis (HP:0004420) | 1.97651588 |
149 | Spontaneous abortion (HP:0005268) | 1.96081383 |
150 | Prostate neoplasm (HP:0100787) | 1.95903514 |
151 | Elevated alkaline phosphatase (HP:0003155) | 1.95667148 |
152 | Abnormal platelet function (HP:0011869) | 1.95592634 |
153 | Impaired platelet aggregation (HP:0003540) | 1.95592634 |
154 | Malnutrition (HP:0004395) | 1.94497231 |
155 | Pulmonary embolism (HP:0002204) | 1.94371399 |
156 | Hemorrhage of the eye (HP:0011885) | 1.94261088 |
157 | Sensorimotor neuropathy (HP:0007141) | 1.94113589 |
158 | Peritonitis (HP:0002586) | 1.93710511 |
159 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93653182 |
160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91739117 |
161 | Fatigue (HP:0012378) | 1.91090891 |
162 | Osteomyelitis (HP:0002754) | 1.89898612 |
163 | Abnormality of proline metabolism (HP:0010907) | 1.89700366 |
164 | Hydroxyprolinuria (HP:0003080) | 1.89700366 |
165 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.89684924 |
166 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.89186140 |
167 | Acne (HP:0001061) | 1.88625707 |
168 | Abnormality of the endocardium (HP:0004306) | 1.87515383 |
169 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85602694 |
170 | Gout (HP:0001997) | 1.85185557 |
171 | Long toe (HP:0010511) | 1.84886809 |
172 | Viral hepatitis (HP:0006562) | 1.83549671 |
173 | Alveolar cell carcinoma (HP:0006519) | 1.83005047 |
174 | Abnormal gallbladder morphology (HP:0012437) | 1.82700058 |
175 | Thyroiditis (HP:0100646) | 1.82043044 |
176 | Amyloidosis (HP:0011034) | 1.80416284 |
177 | Epistaxis (HP:0000421) | 1.79251918 |
178 | Generalized aminoaciduria (HP:0002909) | 1.78943223 |
179 | Acute hepatic failure (HP:0006554) | 1.78551663 |
180 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77922511 |
181 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77922511 |
182 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77922511 |
183 | Abnormality of the prostate (HP:0008775) | 1.77890946 |
184 | Arthralgia (HP:0002829) | 1.77490604 |
185 | Spastic diplegia (HP:0001264) | 1.75534123 |
186 | Cortical dysplasia (HP:0002539) | 1.74717731 |
187 | Periodontitis (HP:0000704) | 1.74576471 |
188 | Tetraparesis (HP:0002273) | 1.72962845 |
189 | Increased mean platelet volume (HP:0011877) | 1.69431186 |
190 | Gastrointestinal infarctions (HP:0005244) | 1.69157368 |
191 | Abnormality of iron homeostasis (HP:0011031) | 1.68360073 |
192 | Cholelithiasis (HP:0001081) | 1.67699569 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.48043360 |
2 | LATS1 | 3.17402462 |
3 | INSRR | 3.09034196 |
4 | RIPK4 | 3.01144295 |
5 | TRIB3 | 2.96596996 |
6 | IRAK3 | 2.58387126 |
7 | GRK6 | 2.56555291 |
8 | PKN2 | 2.50507916 |
9 | SIK1 | 2.45877357 |
10 | EEF2K | 2.40944636 |
11 | PRPF4B | 2.39889158 |
12 | FRK | 2.36148175 |
13 | FGFR4 | 2.21352950 |
14 | BCKDK | 2.18611445 |
15 | FLT3 | 2.07494296 |
16 | PTK6 | 2.06028019 |
17 | FES | 1.98739052 |
18 | BLK | 1.98644541 |
19 | TNK2 | 1.88674626 |
20 | JAK1 | 1.74798750 |
21 | IKBKB | 1.63341638 |
22 | EPHB1 | 1.61037449 |
23 | TYK2 | 1.56395965 |
24 | CDK12 | 1.52291456 |
25 | SYK | 1.51667445 |
26 | PIK3CG | 1.51592587 |
27 | JAK3 | 1.43883096 |
28 | CAMK1D | 1.43402220 |
29 | EPHA3 | 1.41283677 |
30 | AKT3 | 1.40367791 |
31 | HIPK2 | 1.39906977 |
32 | JAK2 | 1.37960850 |
33 | TBK1 | 1.35711414 |
34 | CAMK1G | 1.32803389 |
35 | ERBB4 | 1.31184230 |
36 | STK3 | 1.30939066 |
37 | SIK3 | 1.30196666 |
38 | MAP3K6 | 1.27064208 |
39 | MAP3K2 | 1.27034554 |
40 | LCK | 1.26042380 |
41 | IRAK1 | 1.22084460 |
42 | MARK3 | 1.20481643 |
43 | RIPK1 | 1.19755431 |
44 | NEK9 | 1.19154545 |
45 | MAP2K2 | 1.15308397 |
46 | STK10 | 1.14585983 |
47 | MAPK15 | 1.14115531 |
48 | FGR | 1.13940817 |
49 | MAP4K1 | 1.12318056 |
50 | LYN | 1.11903163 |
51 | MATK | 1.07154513 |
52 | MAPK7 | 1.04653781 |
53 | FGFR3 | 1.04051501 |
54 | MAP2K3 | 1.03336230 |
55 | RET | 1.02961596 |
56 | PDGFRA | 1.02010402 |
57 | MAP3K10 | 1.01592651 |
58 | MTOR | 1.01229153 |
59 | ZAP70 | 1.01144077 |
60 | * TAOK3 | 1.01042765 |
61 | MAPKAPK3 | 1.00676596 |
62 | MAP3K1 | 0.98323223 |
63 | CDK6 | 0.98122971 |
64 | MAP3K14 | 0.96933159 |
65 | PTK2 | 0.94906771 |
66 | PASK | 0.94816373 |
67 | MST1R | 0.94383449 |
68 | MARK2 | 0.94234078 |
69 | SCYL2 | 0.93040986 |
70 | MAP3K3 | 0.92640017 |
71 | MAP3K7 | 0.91590740 |
72 | PDK1 | 0.90419045 |
73 | LRRK2 | 0.89572490 |
74 | TAOK1 | 0.89531160 |
75 | PRKAA2 | 0.87369333 |
76 | BTK | 0.87197909 |
77 | MOS | 0.84656575 |
78 | SIK2 | 0.84603766 |
79 | MAPK11 | 0.83770708 |
80 | CDK9 | 0.83126458 |
81 | KIT | 0.81960226 |
82 | CHUK | 0.81923402 |
83 | TGFBR2 | 0.81883678 |
84 | NUAK1 | 0.80711080 |
85 | MAP3K11 | 0.80079814 |
86 | IRAK2 | 0.79785420 |
87 | MAPK12 | 0.79110874 |
88 | CDC42BPA | 0.76570365 |
89 | ITK | 0.75199982 |
90 | MAP3K13 | 0.74665717 |
91 | PRKCQ | 0.72463919 |
92 | PRKAA1 | 0.71713023 |
93 | IKBKE | 0.71498349 |
94 | SGK3 | 0.70105577 |
95 | YES1 | 0.69965299 |
96 | MELK | 0.67566501 |
97 | TEC | 0.66516670 |
98 | PDGFRB | 0.66463379 |
99 | TTN | 0.64105604 |
100 | NLK | 0.63878019 |
101 | TAOK2 | 0.63371194 |
102 | GRK7 | 0.62748749 |
103 | GSK3A | 0.62277254 |
104 | TXK | 0.60477097 |
105 | STK38 | 0.58840665 |
106 | BRD4 | 0.58809967 |
107 | PRKCH | 0.58069944 |
108 | SGK2 | 0.58047413 |
109 | CAMKK2 | 0.53036395 |
110 | BMX | 0.52903309 |
111 | MAP2K6 | 0.51999925 |
112 | MAP3K8 | 0.49995294 |
113 | KSR2 | 0.49636243 |
114 | WNK1 | 0.49420145 |
115 | MET | 0.48838298 |
116 | IRAK4 | 0.48446259 |
117 | BMPR2 | 0.48383146 |
118 | CSF1R | 0.47889205 |
119 | PTK2B | 0.47576572 |
120 | CSK | 0.46901323 |
121 | CDK4 | 0.46571078 |
122 | DYRK1B | 0.46490990 |
123 | PAK2 | 0.46115948 |
124 | PIK3CA | 0.45630803 |
125 | PIM1 | 0.45066379 |
126 | PRKD2 | 0.44314391 |
127 | HCK | 0.44117978 |
128 | RPS6KC1 | 0.43479577 |
129 | RPS6KL1 | 0.43479577 |
130 | RPS6KA6 | 0.43237657 |
131 | RPS6KA4 | 0.42874754 |
132 | ACVR1B | 0.42305305 |
133 | PDPK1 | 0.42192481 |
134 | RPS6KB2 | 0.41658857 |
135 | MAPKAPK2 | 0.41583681 |
136 | TRPM7 | 0.39468928 |
137 | ABL1 | 0.39359549 |
138 | ERBB2 | 0.38399484 |
139 | IGF1R | 0.35737967 |
140 | EGFR | 0.35203160 |
141 | DMPK | 0.34696818 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.70088159 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.37342947 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31369553 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05182555 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.89829658 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.72494955 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.45822998 |
8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.42604730 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42215249 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32841879 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.23992826 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20434211 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.10677674 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 2.07317274 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04834468 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.03052690 |
17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.02846441 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01687030 |
19 | Measles_Homo sapiens_hsa05162 | 2.01301530 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96659495 |
21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95228691 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91957913 |
23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90261486 |
24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89092482 |
25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85950636 |
26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83159941 |
27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79195217 |
28 | ABC transporters_Homo sapiens_hsa02010 | 1.73152799 |
29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72272456 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64738109 |
31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61924298 |
32 | Malaria_Homo sapiens_hsa05144 | 1.61540466 |
33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60193871 |
34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56707583 |
35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54231877 |
36 | Tuberculosis_Homo sapiens_hsa05152 | 1.53958751 |
37 | Lysine degradation_Homo sapiens_hsa00310 | 1.50962924 |
38 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.50620795 |
39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50410693 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47238249 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.46828972 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46719271 |
43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44151004 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.43299138 |
45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43254303 |
46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42467215 |
47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42426498 |
48 | Peroxisome_Homo sapiens_hsa04146 | 1.42301555 |
49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41082772 |
50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34833683 |
51 | Bile secretion_Homo sapiens_hsa04976 | 1.33817900 |
52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33679902 |
53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32664361 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31972067 |
55 | Legionellosis_Homo sapiens_hsa05134 | 1.26010640 |
56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.25450789 |
57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24563444 |
58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23600778 |
59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22448626 |
60 | Hepatitis B_Homo sapiens_hsa05161 | 1.22341303 |
61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20410713 |
62 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17932464 |
63 | Retinol metabolism_Homo sapiens_hsa00830 | 1.17454061 |
64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17406322 |
65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11922322 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 1.11741034 |
67 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10886394 |
68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10607382 |
69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.06799414 |
70 | Pertussis_Homo sapiens_hsa05133 | 1.02252480 |
71 | Platelet activation_Homo sapiens_hsa04611 | 1.01114328 |
72 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00342866 |
73 | Asthma_Homo sapiens_hsa05310 | 0.98021499 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93905812 |
75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93138145 |
76 | * Apoptosis_Homo sapiens_hsa04210 | 0.92638402 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92478556 |
78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90758821 |
79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88262839 |
80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87452425 |
81 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86726438 |
82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84983148 |
83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83443042 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80577283 |
85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78703945 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.78433585 |
87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77268113 |
88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76643452 |
89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76614192 |
90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72939486 |
91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71559068 |
92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71320351 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70284477 |
94 | Lysosome_Homo sapiens_hsa04142 | 0.69926439 |
95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68917457 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68177355 |
97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65645239 |
98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64409602 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63393158 |
100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61268600 |
101 | Protein export_Homo sapiens_hsa03060 | 0.60858269 |
102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60638112 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60050410 |
104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59514071 |
105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59159691 |
106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59150638 |
107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58872335 |
108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58699173 |
109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58329412 |
110 | Prostate cancer_Homo sapiens_hsa05215 | 0.57983689 |
111 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57629267 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56754085 |
113 | Shigellosis_Homo sapiens_hsa05131 | 0.56488229 |
114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56184050 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54828115 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53640118 |
117 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52564145 |
118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51689451 |
119 | Endocytosis_Homo sapiens_hsa04144 | 0.49910949 |
120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49331023 |
121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49280374 |
122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47799586 |
123 | Prion diseases_Homo sapiens_hsa05020 | 0.47385798 |
124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47369273 |
125 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47256078 |
126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46722196 |
127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46717150 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46386264 |
129 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45578961 |
130 | Phagosome_Homo sapiens_hsa04145 | 0.45279565 |
131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45204850 |
132 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45096885 |
133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44502621 |
134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44079216 |
135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43820373 |
136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43603978 |
137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43161950 |
138 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42861952 |
139 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42562071 |
140 | Salmonella infection_Homo sapiens_hsa05132 | 0.41869621 |
141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41780293 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41551372 |
143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40279555 |
144 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39631843 |
145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39610616 |
146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39014560 |
147 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38835662 |
148 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38748951 |
149 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38167379 |
150 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37566423 |
151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37534292 |
152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37190296 |
153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37033969 |
154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36926497 |
155 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34044513 |
156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33932397 |
157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33487204 |
158 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32655950 |
159 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.32568484 |
160 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28233445 |
161 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28076406 |
162 | Hepatitis C_Homo sapiens_hsa05160 | 0.27974365 |
163 | Bladder cancer_Homo sapiens_hsa05219 | 0.26953205 |
164 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26277089 |
165 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26096003 |
166 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26086329 |
167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25948703 |
168 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25229736 |
169 | Amoebiasis_Homo sapiens_hsa05146 | 0.25059762 |